小児用解熱鎮痛薬の世界市場レポート 2025年

小児用解熱鎮痛薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.6％で44億3,000万米ドルに成長します。予測期間の成長は、より安全な解熱鎮痛薬の需要を高める小児ヘルスケアへの注目の高まり、解熱鎮痛治療の必要性を煽る小児のウイルス感染症の流行拡大、発展途上国における小児ヘルスケアへのアクセスを改善するための政府のイニシアチブの増加、解熱鎮痛薬の有効性を高める製剤やデリバリーメカニズムの進歩、新興市場における製薬企業の拡大が小児用医薬品の入手を促進していることに起因しています。予測期間における主な動向としては、より迅速で安全な解熱のための小児用薬剤製剤の技術革新、天然成分やハーブをベースとした治療へのシフト、発熱管理のための小児用個別化治療への注目の高まり、発熱管理のための小児科診察への遠隔医療プラットフォームの採用拡大、小児の複数の症状をターゲットとした解熱鎮痛薬の併用開発などが挙げられます。

ウイルス感染や細菌感染の増加は、将来的に小児用解熱剤市場の成長を促進すると予想されます。ウイルス感染症は、ウイルスが宿主細胞内に侵入・複製することで発生し、インフルエンザなどの疾病を引き起こします。細菌感染症は、有害な細菌が体内に侵入して増殖することで発生し、溶連菌感染症や結核などの病気を引き起こします。これらの感染症の増加は、抗生物質耐性の増加、世界の旅行、人口密度の増加など、病原体の拡散を促進する要因に起因しています。アセトアミノフェンやイブプロフェンなどの解熱剤は、発熱を抑え、これらの感染症に伴う不快感を和らげるために小児によく使用されます。例えば、英国に本部を置く省庁ではない国家統計局の報告によると、2021年12月から2022年3月までの間に、英国でインフルエンザや肺炎による死亡者は6,898人で、2020年から2021年の同時期の5,288人から増加しています。これは、前年比で1,600人以上死亡者が増加したことになります。その結果、ウイルスおよび細菌感染症の罹患率の上昇が、小児用解熱剤市場の成長を後押ししています。

出生率の増加が小児用解熱剤市場の成長に寄与すると予想されます。出生率とは、人口1,000人当たりの年間出生数のことです。この増加は、ヘルスケアへのアクセスの向上、経済状況の改善、特定の地域における出生率の上昇に起因すると考えられます。出生率の上昇は、小児用解熱鎮痛薬に対する需要の増大につながります。乳幼児の人口が増えれば、発熱管理を含むより多くの医療ケアが必要となるからです。例えば、オーストラリアを拠点とする電子リソースであるRegistry of Births, Deaths, and Marriages in Victoriaによると、ビクトリア州で登録された出生数は、2024年7月の7,689人から2024年8月には7,994人に増加しました。したがって、出生率の増加が小児用解熱剤市場を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界小児用解熱鎮痛薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の小児用解熱鎮痛薬市場：成長率分析
• 世界の小児用解熱鎮痛薬市場の実績：規模と成長, 2019-2024
• 世界の小児用解熱鎮痛薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界小児用解熱鎮痛薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の小児用解熱鎮痛薬市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アセトアミノフェン
• イブプロフェン
• その他の薬物クラス
• 世界の小児用解熱鎮痛薬市場剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• シロップ
• 坐薬
• その他の剤形
• 世界の小児用解熱鎮痛薬市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 新生児
• 乳児
• 幼児
• 子供たち
• 世界の小児用解熱鎮痛薬市場アセトアミノフェンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口懸濁液
• チュアブル錠
• 坐薬
• 世界の小児用解熱鎮痛薬市場イブプロフェンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口懸濁液
• チュアブル錠
• 坐薬
• 世界の小児用解熱鎮痛薬市場、その他の薬物クラスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アスピリン
• ナプロキセン

第7章 地域別・国別分析

• 世界の小児用解熱鎮痛薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の小児用解熱鎮痛薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 小児用解熱鎮痛薬市場：競合情勢
• 小児用解熱鎮痛薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• Bristol Myers Squibb
• GlaxoSmithKline plc
• Reckitt Benckiser Group
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company plc
• Aurobindo Pharma Ltd.
• Dr. Reddy's Laboratories Ltd.
• Cipla Ltd.
• Lupin Limited
• Towa Pharmaceutical Co Ltd
• Glenmark Pharmaceuticals Ltd.
• Alkem Laboratories Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 小児用解熱鎮痛薬市場2029：新たな機会を提供する国
• 小児用解熱鎮痛薬市場2029：新たな機会を提供するセグメント
• 小児用解熱鎮痛薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Antipyretic drugs for children are medications specifically designed to reduce fever. They function by lowering the body's temperature through various mechanisms, including the inhibition of fever-inducing substances. These drugs help alleviate discomfort and prevent complications related to high fever in children.

The primary classes of antipyretic drugs for children include acetaminophen, ibuprofen, and others. Acetaminophen, also known as paracetamol, is an analgesic and antipyretic medication that provides pain relief and reduces fever without having anti-inflammatory properties. Available dosage forms include tablets, syrups, suppositories, and others, tailored for different age groups, such as newborns, infants, toddlers, and children.

The antipyretic drugs for children market research report is one of a series of new reports from The Business Research Company that provides antipyretic drugs for children market statistics, including antipyretic drugs for children industry global market size, regional shares, competitors with a antipyretic drugs for children market share, detailed antipyretic drugs for children market segments, market trends and opportunities, and any further data you may need to thrive in the antipyretic drugs for children industry. This antipyretic drugs for children market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The antipyretic drugs for children market size has grown strongly in recent years. It will grow from $3.21 billion in 2024 to $3.43 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increasing awareness of pediatric health leading to higher demand for antipyretic medications, growing incidence of fever-related illnesses in children worldwide, rising healthcare expenditures among families to treat common childhood fevers, increasing access to over-the-counter antipyretic drugs in emerging markets and growing emphasis on preventive healthcare and early treatment of pediatric fevers.

The antipyretic drugs for children market size is expected to see strong growth in the next few years. It will grow to $4.43 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising focus on pediatric healthcare advancements boosting the demand for safer antipyretic drugs, growing prevalence of viral infections in children fueling the need for antipyretic treatments, increasing government initiatives to improve pediatric healthcare access in developing countries, advances in drug formulations and delivery mechanisms enhancing the efficacy of antipyretics and expansion of pharmaceutical companies in emerging markets driving the availability of pediatric medications. Major trends in the forecast period include technological innovations in pediatric drug formulations for faster and safer fever relief, shift towards natural and herbal-based antipyretic drugs for children, increasing focus on personalized pediatric treatments for managing fevers, growing adoption of telemedicine platforms to access pediatric consultations for fever management and development of combination antipyretic drugs targeting multiple symptoms in children.

The increasing prevalence of viral and bacterial infections is expected to drive growth in the antipyretic drugs market for children in the future. Viral infections occur when viruses invade and replicate within host cells, leading to diseases such as influenza (flu). Bacterial infections arise from harmful bacteria entering the body and multiplying, causing illnesses such as strep throat or tuberculosis. The rise in these infections can be attributed to factors such as growing antibiotic resistance, global travel, and increased population density, which facilitate the spread of pathogens. Antipyretic drugs, including acetaminophen and ibuprofen, are commonly used in children to reduce fever and alleviate discomfort associated with these infections. For example, the Office for National Statistics, a UK-based non-ministerial department, reported that between December 2021 and March 2022, there were 6,898 deaths due to flu and pneumonia in the UK, up from 5,288 deaths in the same period of 2020-2021. This represents an increase of over 1,600 deaths year-over-year. Consequently, the rising incidence of viral and bacterial infections is fueling the growth of the antipyretic drugs market for children.

The increasing birth rates are expected to contribute to the growth of the antipyretic drug market for children. The birth rate refers to the number of live births per 1,000 people in a population each year. This increase can be attributed to better access to healthcare, improved economic conditions, and higher fertility rates in certain regions. A higher birth rate leads to greater demand for antipyretic drugs for children, as a larger population of infants and young children necessitates more medical care, including fever management. For instance, the Registry of Births, Deaths, and Marriages in Victoria, an electronic resource based in Australia, reported that the number of births registered in Victoria rose from 7,689 in July 2024 to 7,994 in August 2024. Therefore, the growing birth rates are driving the antipyretic drug market for children.

Key players in the antipyretic drugs market for children are concentrating on developing advanced drug formulations, such as medicine gummy bites, to improve ease of administration and enhance compliance among young patients. Medicine gummy bites are chewable, gummy medications designed to make taking medicine more appealing, especially for children. They come in various forms and flavors to encourage compliance and simplify the process. For example, in October 2023, DrKids, a US-based pharmaceutical company, launched an acetaminophen gummy bite. This innovative medication provides a child-friendly alternative for pain and fever relief and features an exact dosing system that simplifies medicine administration for parents while ensuring safety and effectiveness.

Major companies operating in the antipyretic drugs for children market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, GlaxoSmithKline plc, Reckitt Benckiser Group, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Limited, Towa Pharmaceutical Co Ltd, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Limited

North America was the largest region in the antipyretic drugs for children market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipyretic drugs for children market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antipyretic drugs for children market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antipyretic drugs for children market consists of sales of acetaminophen (tylenol), ibuprofen (advil, motrin), and naproxen (aleve). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antipyretic Drugs For Children Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antipyretic drugs for children market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antipyretic drugs for children ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antipyretic drugs for children market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Acetaminophen; Ibuprofen; Other Drug Classes
• 2) By Dosage Form: Tablets; Syrups; Suppositories; Other Dosage Forms
• 3) By Age Group: Newborns; Infants; Toddlers; Children
• Subsegments:
• 1) By Acetaminophen: Oral Suspension; Chewable Tablets; Suppositories
• 2) By Ibuprofen: Oral Suspension; Chewable Tablets; Suppositories
• 3) By Other Drug Classes: Aspirin; Naproxen
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antipyretic Drugs For Children Market Characteristics

3. Antipyretic Drugs For Children Market Trends And Strategies

4. Antipyretic Drugs For Children Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Antipyretic Drugs For Children Growth Analysis And Strategic Analysis Framework

• 5.1. Global Antipyretic Drugs For Children PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Antipyretic Drugs For Children Market Growth Rate Analysis
• 5.4. Global Antipyretic Drugs For Children Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Antipyretic Drugs For Children Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Antipyretic Drugs For Children Total Addressable Market (TAM)

6. Antipyretic Drugs For Children Market Segmentation

• 6.1. Global Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acetaminophen
• Ibuprofen
• Other Drug Classes
• 6.2. Global Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Syrups
• Suppositories
• Other Dosage Forms
• 6.3. Global Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Newborns
• Infants
• Toddlers
• Children
• 6.4. Global Antipyretic Drugs For Children Market, Sub-Segmentation Of Acetaminophen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Suspension
• Chewable Tablets
• Suppositories
• 6.5. Global Antipyretic Drugs For Children Market, Sub-Segmentation Of Ibuprofen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Suspension
• Chewable Tablets
• Suppositories
• 6.6. Global Antipyretic Drugs For Children Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aspirin
• Naproxen

7. Antipyretic Drugs For Children Market Regional And Country Analysis

• 7.1. Global Antipyretic Drugs For Children Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Antipyretic Drugs For Children Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antipyretic Drugs For Children Market

• 8.1. Asia-Pacific Antipyretic Drugs For Children Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antipyretic Drugs For Children Market

• 9.1. China Antipyretic Drugs For Children Market Overview
• 9.2. China Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antipyretic Drugs For Children Market

• 10.1. India Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antipyretic Drugs For Children Market

• 11.1. Japan Antipyretic Drugs For Children Market Overview
• 11.2. Japan Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antipyretic Drugs For Children Market

• 12.1. Australia Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antipyretic Drugs For Children Market

• 13.1. Indonesia Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antipyretic Drugs For Children Market

• 14.1. South Korea Antipyretic Drugs For Children Market Overview
• 14.2. South Korea Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antipyretic Drugs For Children Market

• 15.1. Western Europe Antipyretic Drugs For Children Market Overview
• 15.2. Western Europe Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antipyretic Drugs For Children Market

• 16.1. UK Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antipyretic Drugs For Children Market

• 17.1. Germany Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antipyretic Drugs For Children Market

• 18.1. France Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antipyretic Drugs For Children Market

• 19.1. Italy Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antipyretic Drugs For Children Market

• 20.1. Spain Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antipyretic Drugs For Children Market

• 21.1. Eastern Europe Antipyretic Drugs For Children Market Overview
• 21.2. Eastern Europe Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antipyretic Drugs For Children Market

• 22.1. Russia Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antipyretic Drugs For Children Market

• 23.1. North America Antipyretic Drugs For Children Market Overview
• 23.2. North America Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antipyretic Drugs For Children Market

• 24.1. USA Antipyretic Drugs For Children Market Overview
• 24.2. USA Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antipyretic Drugs For Children Market

• 25.1. Canada Antipyretic Drugs For Children Market Overview
• 25.2. Canada Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antipyretic Drugs For Children Market

• 26.1. South America Antipyretic Drugs For Children Market Overview
• 26.2. South America Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antipyretic Drugs For Children Market

• 27.1. Brazil Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antipyretic Drugs For Children Market

• 28.1. Middle East Antipyretic Drugs For Children Market Overview
• 28.2. Middle East Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antipyretic Drugs For Children Market

• 29.1. Africa Antipyretic Drugs For Children Market Overview
• 29.2. Africa Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antipyretic Drugs For Children Market Competitive Landscape And Company Profiles

• 30.1. Antipyretic Drugs For Children Market Competitive Landscape
• 30.2. Antipyretic Drugs For Children Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Antipyretic Drugs For Children Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol Myers Squibb
• 31.3. GlaxoSmithKline plc
• 31.4. Reckitt Benckiser Group
• 31.5. Viatris Inc.
• 31.6. Teva Pharmaceutical Industries Ltd.
• 31.7. Sun Pharmaceutical Industries Ltd.
• 31.8. Perrigo Company plc
• 31.9. Aurobindo Pharma Ltd.
• 31.10. Dr. Reddy's Laboratories Ltd.
• 31.11. Cipla Ltd.
• 31.12. Lupin Limited
• 31.13. Towa Pharmaceutical Co Ltd
• 31.14. Glenmark Pharmaceuticals Ltd.
• 31.15. Alkem Laboratories Limited

32. Global Antipyretic Drugs For Children Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antipyretic Drugs For Children Market

34. Recent Developments In The Antipyretic Drugs For Children Market

35. Antipyretic Drugs For Children Market High Potential Countries, Segments and Strategies

• 35.1 Antipyretic Drugs For Children Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Antipyretic Drugs For Children Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Antipyretic Drugs For Children Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer